| abstract |
REFERS TO A COMPOUND THAT INCLUDES REGIONS; THE REGION MAY BE HETEROPHENYL METHYLENE REMAINS OF FORMULA 1; WHERE R5 IS A LINK, O, CO, NR4, S (= O) p; R4 IS H, C1-C2 ALKYL; R6 IS H, C1-C2 ALKYL, C1-C2 ALCOXY, CN, OH, C = ONH2; j, m, p ARE 0-2; R7 AND R8 ARE F, Cl, OH, CN, CONR4aR4b, AMONG OTHERS; R4a AND R4b ARE H, C1-C2 ALKYL; THE REST 1.0.1 IS A SINGLE CYCLE HETEROCYCLE, BENZOCONDENSED BIKE; R12a IS F, Cl, CO2R4, OXO, AMONG OTHERS; R9 IS F, Cl, CO2R4, OH, CN, AMONG OTHERS; R12b IS H, C1-C4 ALKYL, C2-C4 ALKYL, AMONG OTHERS; THE REGION IS -C (R40) -C (R41) -; R40 AND R41 ARE H, ALKYL, OH, C1-C3 ALCOXY; THE REGION IS AN AZABICYCLE (4.2.0, W4 IS A LINK, CH2, CH2-O-CH2, AMONG OTHERS; THE REGION IS A 5-MEMBER HETEROCYCLE WITH 2 N, AMIDE, CARBAMATE, UREA, AMONG OTHERS; A PREFERRED COMPOUND ES N- {3- [3-EXO- (2-METHYL-1H-BENZOIMIDAZOL-1-IL) -ß-AZABICYCLO [3.2.1.] OCT-8-IL] -1-PHENYLPROPYL} -CYCLOBUTANOCARBOXAMIDE, AMONG OTHERS IT ALSO REFERS TO A COMPOSITION THAT ALSO INCLUDES INDINAVIR, SAQUINAVIR, NELFINAVIR, AMPRENAVIR, NEVIRAPINA, DELAVIRDINA, EFAVIRENZ, ZIDOVUDINE, DIDANOSINE, ZALCITABINA, ESTAVUDO ENGINEERING COMPOSITION, ADEFACULVUDINA, ADEFACULVUDINA, ADEFACIVUDINA, MODEL RECOMMODE RECOMMENO, ESTAVUDO RECOMMODINE, ADEFACOVUDINA. CHEMOKINE CCR5 AND MAY BE USEFUL FOR THE TREATMENT OF AN INFECTION WITH THE HUMAN IMMUDEFICIENCY VIRUS |